Two cycles versus three cyclle of CCRT for low risk locoregionally advanced nasopharyngeal carcinoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
This is a Phase II trial to study the effectiveness of two cycles versus three cycles of Concurrent Chemoradiotherapy in treating patients with Low Risk Locoregionally Advanced Nasopharyngeal Carcinoma based on pretreatment plasma EBV DNA.
Epistemonikos ID: 51b07abbcea7fba471cd81adda9cfa99740c2f64
First added on: May 17, 2024